Clinical Trial Update: Comparing the Efficacy and Safety Between Continuous Subcutaneous Beinaglutide and CSII for Newly Diagnosed T2DM Patients [NA]

View source ↗

Summary

A clinical trial comparing continuous subcutaneous beinaglutide with insulin delivered by continuous subcutaneous infusion (CSII) in newly diagnosed type 2 diab…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Beinaglutide (beinaglutide)

Snippet

Sponsor: Beijing Hospital | Conditions: Type 2 Diabetic Patients, T2DM (Type 2 Diabetes Mellitus) | NA | Status: RECRUITING